Genetic Testing

WASHINGTON — Genetic testing has increased the number of patients diagnosed with primary immunodeficiencies, Eveline Wu, MD, MSCR, told Healio during the American Academy of Allergy, Asthma & Immunology Annual Meeting.

Sudden death from cardiac causes is among the leading causes of death in the United States, yet predicting who might be at high risk remains a difficult task.

ORLANDO — Genetic testing, which is likely to identify underlying genetic causes for the condition, should be a component of diagnostic evaluations for adult patients with epilepsy, according to new research.

An estimated 18.1 million cancer survivors live in the United States, and that number is expected to exceed 22 million by 2030.

NASHVILLE, Tenn. — Fewer than one in 20 patients with kidney cancer who meet guidelines for genetic evaluation received genetic counseling, according to findings presented at International Kidney Cancer Symposium: North America.

VANCOUVER, British Columbia — A digital risk assessment tool and genetic testing program can be helpful in identifying patients with high-risk cancer susceptibility syndromes, according to a presenter at the ACG Annual Scientific Meeting.

A new set of evidence-based guidelines for ALS genetic testing are focused on improving knowledge among all stakeholders, according to a report in the Annals of Clinical and Translational Neurology.

Advances in genetic testing have created unprecedented opportunities for cancer survivors and their relatives to learn about individual or familial cancer risks.

PHILADELPHIA — A genetic risk test for patients with multiple sclerosis can identify drugs that may lead to development of progressive multifocal leukoencephalopathy, per data presented at the American Neurological Association annual meeting.

Identification of inherited genetic mutations that elevate cancer risk and may be susceptible to targeted therapies has transformed oncology care.